nrix-ex231_159.htm

EX-23.1 6 nrix-ex231_159.htm EX-23.1 nrix-ex231_159.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-240065) of Nurix Therapeutics, Inc. of our report dated February 16, 2021 relating to the financial statements, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

San Jose, California

February 16, 2021